Turku Clinical Research Center (Turku CRC)
Research facility
Location:
Turku,
Finland (FI)
ISNI: 0000000120971371
ROR: https://ror.org/05vghhr25
Show on Map:
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease (2024)
Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, Popp A, et al.
Journal article
A randomized trial of a transglutaminase 2 inhibitor for celiac disease (2021)
Schuppan D, Mäki M, Lundin KE, Isola J, Friesing-Sosnik T, Taavela J, Popp A, et al.
Journal article